研究生: |
徐子凡 Hsu, Zih-Fan |
---|---|
論文名稱: |
探討雙高石膽酸衍生物對於唾液酸轉移酶及癌細胞轉移的影響 Bishomolithocholic Acid: A Unique Template for Human Sialyltransferase Inhibitor, Optimized to Suppress Cancer Metastasis |
指導教授: |
李文山
Li, Wen-Shan 林文偉 Lin, Wen-Wei |
學位類別: |
碩士 Master |
系所名稱: |
化學系 Department of Chemistry |
論文出版年: | 2019 |
畢業學年度: | 107 |
語文別: | 英文 |
論文頁數: | 96 |
中文關鍵詞: | 唾液酸 、唾液酸轉移酶 、癌症轉移 、雙高石膽酸 |
英文關鍵詞: | sialic acid, sialyltransferase, metastasis, bishomolithocholic acid |
DOI URL: | http://doi.org/10.6345/NTNU201900320 |
論文種類: | 學術論文 |
相關次數: | 點閱:104 下載:0 |
分享至: |
查詢本校圖書館目錄 查詢臺灣博碩士論文知識加值系統 勘誤回報 |
1. 衛生福利部統計處, (2018), 106年主要死因統計結果分析, Retrieved May, 30, 2019, from https://dep.mohw.gov.tw/DOS/cp-3960-41756-113.html.
2. Chaffer, C. L.; Weinberg, R. A. A perspective on cancer cell metastasis, Science 2011, 331, 1559-1564.
3. Steeg, P. S. Targeting metastasis, Nat. Rev. Cancer 2016, 16, 201-218.
4. Vajaria, B. N.; Patel, P. S. Glycosylation: A hallmark of cancer?, Glycoconj. J. 2017, 34, 147-156.
5. Pinho, S. S.; Reis, C. A. Glycosylation in cancer: Mechanisms and clinical implications, Nat. Rev. Cancer 2015, 15, 540-555.
6. Bull, C.; Stoel, M. A.; den Brok, M. H.; Adema, G. J. Sialic acids sweeten a tumor's life, Cancer Res. 2014, 74, 3199-3204.
7. Rodrigues, J. G.; Balmana, M.; Macedo, J. A.; Pocas, J.; Fernandes, A.; de-Freitas-Junior, J. C. M.; Pinho, S. S.; Gomes, J.; Magalhaes, A.; Gomes, C.; Mereiter, S.; Reis, C. A. Glycosylation in cancer: Selected roles in tumour progression, immune modulation and metastasis, Cell. Immunol. 2018, 333, 46-57.
8. Lu, J.; Gu, J. Significance of beta-galactoside alpha2,6 sialyltranferase 1 in cancers, Molecules 2015, 20, 7509-7527.
9. Wang, L.; Liu, Y.; Wu, L.; Sun, X. L. Sialyltransferase inhibition and recent advances, Biochim. Biophys. Acta 2016, 1864, 143-153.
10. Yarema, K. J.; Goon, S.; Bertozzi, C. R. Metabolic selection of glycosylation defects in human cells, Nat. Biotechnol. 2001, 19, 553-558.
11. Li, F.; Ding, J. Sialylation is involved in cell fate decision during development, reprogramming and cancer progression, Protein Cell 2018, doi:10.1007/s13238-13018-10597-13235.
12. Wang, X.; Zhang, L. H.; Ye, X. S. Recent development in the design of sialyltransferase inhibitors, Med. Res. Rev. 2003, 23, 32-47.
13. Szabo, R.; Skropeta, D. Advancement of sialyltransferase inhibitors: Therapeutic challenges and opportunities, Med. Res. Rev. 2017, 37, 219-270.
14. Rodrigues, E.; Macauley, M. S. Hypersialylation in cancer: Modulation of inflammation and therapeutic opportunities, Cancers (Basel) 2018, 10, 207.
15. Pearce, O. M.; Laubli, H. Sialic acids in cancer biology and immunity, Glycobiology 2016, 26, 111-128.
16. Amano, M.; Galvan, M.; He, J.; Baum, L. G. The ST6Gal I sialyltransferase selectively modifies N-glycans on CD45 to negatively regulate galectin-1-induced CD45 clustering, phosphatase modulation, and T cell death, J. Biol. Chem. 2003, 278, 7469-7475.
17. Zhuo, Y.; Chammas, R.; Bellis, S. L. Sialylation of beta1 integrins blocks cell adhesion to galectin-3 and protects cells against galectin-3-induced apoptosis, J. Biol. Chem. 2008, 283, 22177-22185.
18. Joy Burchell, R. P., Andrew Hanby, Caroline Whitehouse, Lucienne Cooper, Henrik Clausen, David Miles and Joyce Taylor-Papadimitriou An α 2,3 sialyltransferase (ST3Gal I) is elevated in primary breast carcinomas, Glycobiology 1999, 9, 1307-1311.
19. Glavey, S. V.; Manier, S.; Natoni, A.; Sacco, A.; Moschetta, M.; Reagan, M. R.; Murillo, L. S.; Sahin, I.; Wu, P.; Mishima, Y.; Zhang, Y.; Zhang, W.; Zhang, Y.; Morgan, G.; Joshi, L.; Roccaro, A. M.; Ghobrial, I. M.; O'Dwyer, M. E. The sialyltransferase ST3Gal6 influences homing and survival in multiple myeloma, Blood 2014, 124, 1765-1776.
20. Gomes, C.; Osorio, H.; Pinto, M. T.; Campos, D.; Oliveira, M. J.; Reis, C. A. Expression of ST3Gal4 leads to SLe(x) expression and induces c-met activation and an invasive phenotype in gastric carcinoma cells, PLoS One 2013, 8, e66737.
21. Perez-Garay, M.; Arteta, B.; Pages, L.; de Llorens, R.; de Bolos, C.; Vidal-Vanaclocha, F.; Peracaula, R. Alpha2,3-sialyltransferase ST3Gal III modulates pancreatic cancer cell motility and adhesion in vitro and enhances its metastatic potential in vivo, PLoS One 2010, 5, e12524.
22. Julien, S.; Adriaenssens, E.; Ottenberg, K.; Furlan, A.; Courtand, G.; Vercoutter-Edouart, A. S.; Hanisch, F. G.; Delannoy, P.; Le Bourhis, X. ST6GalNAc I expression in MDA-MB-231 breast cancer cells greatly modifies their O-glycosylation pattern and enhances their tumourigenicity, Glycobiology 2006, 16, 54-64.
23. Gong, L.; Zhou, X.; Yang, J.; Jiang, Y.; Yang, H. Effects of the regulation of polysialyltransferase ST8SiaII on the invasiveness and metastasis of small cell lung cancer cells, Oncol. Rep. 2017, 37, 131-138.
24. Kedmi, R.; Peer, D. Zooming in on selectins in cancer, Sci. Transl. Med. 2016, 8, 345fs311.
25. Borsig, L. Selectins in cancer immunity, Glycobiology 2018, 28, 648-655.
26. Kannagi, R.; Izawa M Fau - Koike, T.; Koike T Fau - Miyazaki, K.; Miyazaki K Fau - Kimura, N.; Kimura, N. Carbohydrate-mediated cell adhesion in cancer metastasis and angiogenesis, Cancer Sci. 2004, 95, 377-384.
27. Munkley, J. The glycosylation landscape of pancreatic cancer, Oncol. Lett. 2019, 17, 2569-2575.
28. Fu, C.; Zhao, H.; Wang, Y.; Cai, H.; Xiao, Y.; Zeng, Y.; Chen, H. Tumor-associated antigens: Tn antigen, STn antigen, and T antigen, HLA 2016, 88, 275-286.
29. Munkley, J. The role of sialyl-Tn in cancer, Int J Mol Sci 2016, 17, 275.
30. Munkley, J.; Oltean, S.; Vodak, D.; Wilson, B. T.; Livermore, K. E.; Zhou, Y.; Star, E.; Floros, V. I.; Johannessen, B.; Knight, B.; McCullagh, P.; McGrath, J.; Crundwell, M.; Skotheim, R. I.; Robson, C. N.; Leung, H. Y.; Harries, L. W.; Rajan, P.; Mills, I. G.; Elliott, D. J. The androgen receptor controls expression of the cancer-associated STn antigen and cell adhesion through induction of ST6GalNAc1 in prostate cancer, Oncotarget 2015, 6, 34358-34374.
31. Beatson, R.; Maurstad, G.; Picco, G.; Arulappu, A.; Coleman, J.; Wandell, H. H.; Clausen, H.; Mandel, U.; Taylor-Papadimitriou, J.; Sletmoen, M.; Burchell, J. M. The breast cancer-associated glycoforms of muc1, muc1-Tn and sialyl-Tn, are expressed in cosmc wild-type cells and bind the C-type lectin MGL, PLoS One 2015, 10, e0125994.
32. Elkashef, S. M.; Allison, S. J.; Sadiq, M.; Basheer, H. A.; Ribeiro Morais, G.; Loadman, P. M.; Pors, K.; Falconer, R. A. Polysialic acid sustains cancer cell survival and migratory capacity in a hypoxic environment, Sci. Rep. 2016, 6, 33026.
33. Colley, K. J.; Kitajima K Fau - Sato, C.; Sato, C. Polysialic acid: Biosynthesis, novel functions and applications, Crit. Rev. Biochem. Mol. Biol. 2014, 49, 1549-7798.
34. Hamamura, K.; Furukawa, K. Glycosylation is involved in malignant properties of cancer cells, Cancer Transl. Med. 2017, 3, 209-213.
35. Gomez-Cuadrado, L.; Tracey, N.; Ma, R.; Qian, B.; Brunton, V. G. Mouse models of metastasis: Progress and prospects, Dis. Model. Mech. 2017, 10, 1061-1074.
36. Mazzocca, A.; Carloni, V. The metastatic process: Methodological advances and pharmacological challenges, Curr. Med. Chem. 2009, 16, 1704-1717.
37. Bull, C.; Heise, T.; Adema, G. J.; Boltje, T. J. Sialic acid mimetics to target the sialic acid-siglec axis, Trends Biochem. Sci. 2016, 41, 519-531.
38. Bull, C.; Boltje, T. J.; van Dinther, E. A.; Peters, T.; de Graaf, A. M.; Leusen, J. H.; Kreutz, M.; Figdor, C. G.; den Brok, M. H.; Adema, G. J. Targeted delivery of a sialic acid-blocking glycomimetic to cancer cells inhibits metastatic spread, ACS Nano 2015, 9, 733-745.
39. Rillahan, C. D.; Antonopoulos, A.; Lefort, C. T.; Sonon, R.; Azadi, P.; Ley, K.; Dell, A.; Haslam, S. M.; Paulson, J. C. Global metabolic inhibitors of sialyl- and fucosyltransferases remodel the glycome, Nat. Chem. Biol. 2012, 8, 661-668.
40. Macauley, M. S.; Arlian, B. M.; Rillahan, C. D.; Pang, P. C.; Bortell, N.; Marcondes, M. C.; Haslam, S. M.; Dell, A.; Paulson, J. C. Systemic blockade of sialylation in mice with a global inhibitor of sialyltransferases, J. Biol. Chem. 2014, 289, 35149-35158.
41. Pauling, L. Molecular architecture and biological reactions, Chem. Eng. News 1946, 24, 1375-1377.
42. Guo, J.; Li, W.; Xue, W.; Ye, X. S. Transition state-based sialyltransferase inhibitors: Mimicking oxocarbenium ion by simple amide, J. Med. Chem. 2017, 60, 2135-2141.
43. Li, W.; Niu, Y.; Xiong, D. C.; Cao, X.; Ye, X. S. Highly substituted cyclopentane-CMP conjugates as potent sialyltransferase inhibitors, J. Med. Chem. 2015, 58, 7972-7990.
44. Kajihara, Y.; Kodama H Fau - Wakabayashi, T.; Wakabayashi T Fau - Sato, K.; Sato K Fau - Hashimoto, H.; Hashimoto, H. Characterization of inhibitory activities and binding mode of synthetic 6'-modified methyl N-acetyl-beta-lactosaminide toward rat liver CMP-D-Neu5Ac: D-galactoside-(2-->6)-alpha-d-sialyltransferase, Carbohydr Res. 1993, 247, 179-193.
45. Lin, T. W.; Chang, W. W.; Chen, C. C.; Tsai, Y. C. Stachybotrydial, a potent inhibitor of fucosyltransferase and sialyltransferase, Biochem. Biophys. Res. Commun. 2005, 331, 953-957.
46. Wu, C. Y.; Hsu, C. C.; Chen, S. T.; Tsai, Y. C. Soyasaponin I, a potent and specific sialyltransferase inhibitor, Biochem. Biophys. Res. Commun. 2001, 284, 466-469.
47. Hsu, C. C.; Lin, T. W.; Chang, W. W.; Wu, C. Y.; Lo, W. H.; Wang, P. H.; Tsai, Y. C. Soyasaponin-I-modified invasive behavior of cancer by changing cell surface sialic acids, Gynecol. Oncol. 2005, 96, 415-422.
48. Chang, K. H.; Lee, L.; Chen, J.; Li, W. S. Lithocholic acid analogues, new and potent alpha-2,3-sialyltransferase inhibitors, Chem. Commun. (Camb.) 2006, 14, 629-631.
49. Chen, J. Y.; Tang, Y. A.; Huang, S. M.; Juan, H. F.; Wu, L. W.; Sun, Y. C.; Wang, S. C.; Wu, K. W.; Balraj, G.; Chang, T. T.; Li, W. S.; Cheng, H. C.; Wang, Y. C. A novel sialyltransferase inhibitor suppresses FAK/paxillin signaling and cancer angiogenesis and metastasis pathways, Cancer. Res. 2011, 71, 473-483.
50. 傅志偉, 由自然界靈感設計及合成出抗癌症和抗癌症轉移試劑:細胞和動物體內之活性測試評估, 國立中央大學化學學系博士論文, 2015.
51. Siegel, R. L.; Miller, K. D.; Jemal, A. Cancer statistics, 2019, CA Cancer J Clin 2019, 69, 7-34.
52. Aysola, K.; Desai, A.; Welch, C.; Xu, J.; Qin, Y.; Reddy, V.; Matthews, R.; Owens, C.; Okoli, J.; Beech, D. J.; Piyathilake, C. J.; Reddy, S. P.; Rao, V. N. Triple negative breast cancer - an overview, Hereditary Genet 2013, Suppl 2, 001.
53. Ma, X.; Dong, W.; Su, Z.; Zhao, L.; Miao, Y.; Li, N.; Zhou, H.; Jia, L. Functional roles of sialylation in breast cancer progression through miR-26a/26b targeting ST8Sia4, Cell Death Dis. 2016, 7, e2561.
54. Lu, J.; Isaji, T.; Im, S.; Fukuda, T.; Hashii, N.; Takakura, D.; Kawasaki, N.; Gu, J. Beta-galactoside alpha2,6-sialyltranferase 1 promotes transforming growth factor-beta-mediated epithelial-mesenchymal transition, J. Biol. Chem. 2014, 289, 34627-34641.
55. Frohlich, T.; Reiter, C.; Saeed, M. E. M.; Hutterer, C.; Hahn, F.; Leidenberger, M.; Friedrich, O.; Kappes, B.; Marschall, M.; Efferth, T.; Tsogoeva, S. B. Synthesis of thymoquinone-artemisinin hybrids: New potent antileukemia, antiviral, and antimalarial agents, ACS Med Chem Lett 2018, 9, 534-539.
56. Luu, T. H.; Bard, J. M.; Carbonnelle, D.; Chaillou, C.; Huvelin, J. M.; Bobin-Dubigeon, C.; Nazih, H. Lithocholic bile acid inhibits lipogenesis and induces apoptosis in breast cancer cells, Cell Oncol (Dorder) 2018, 41, 13-24.
57. Fu, C.-W.; Chang, K.-H.; Jen, Y. C.; Chang, T. T.; Li, W.-S. Synthesis of amino acid-comprising sialyltransferase inhibitors and their antimetastatic activities against human breast cancer cells, J. Chin. Chem. Soc. 2016, 63, 171-180.
58. Legeay, J. C.; Vanden Eynde, J. J.; Bazureau, J. P. Sequential synthesis of a new analogue of amlodipine bearing a short amino polyethyleneglycol chain, Tetrahedron 2007, 63, 12081-12086.
59. Sofia Svedhem, C.-A. H., Jing Shi, Peter Konradsson, Bo Liedberg, and Stefan C. T. Svensson Synthesis of a series of oligo(ethylene glycol)-terminated alkanethiol amides designed to address structure and stability of biosensing interfaces, J. Org. Chem. 2001, 4494-4503.
60. Aucagne, V.; Valverde, I. E.; Marceau, P.; Galibert, M.; Dendane, N.; Delmas, A. F. Towards the simplification of protein synthesis: Iterative solid-supported ligations with concomitant purifications, Angew. Chem. Int. Ed. Engl. 2012, 51, 11320-11324.